Similar articles

• Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.

  Al-Yaman F, Genton B, Mokela D, Alpers MP. Al-Yaman F, et al. P N G Med J. 1994 Mar;37(1):54-6. P N G Med J. 1994. PMID: 7863730 No abstract available.
• Selection and synergy in Plasmodium falciparum.

  Sims P, Wang P, Hyde JE. Sims P, et al. Parasitol Today. 1999 Apr;15(4):132-4. doi: 10.1016/s0169-4758(99)01420-9. Parasitol Today. 1999. PMID: 10322332 No abstract available.
• More on 'the efficacy of antifolate antimalarial combinations in Africa'.

  Watkins WM, Mberu EK, Winstanley PA, Plowe CV. Watkins WM, et al. Parasitol Today. 1999 Apr;15(4):131-2. doi: 10.1016/s0169-4758(99)01419-2. Parasitol Today. 1999. PMID: 10322331 No abstract available.
• Therapeutic potential of folate uptake inhibition in Plasmodium falciparum.

  Nzila AM, Kokwaro G, Winstanley PA, Marsh K, Ward SA. Nzila AM, et al. Trends Parasitol. 2004 Mar;20(3):109-12. doi: 10.1016/j.pt.2003.12.005. Trends Parasitol. 2004. PMID: 16676416 Review.
• Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

  Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Nzila AM. Sibley CH, et al. Trends Parasitol. 2001 Dec;17(12):582-8. doi: 10.1016/s1471-4922(01)02085-2. Trends Parasitol. 2001. PMID: 11756042 Review.